活细胞成像市场规模、份额、成长分析、按产品和服务、按应用、按技术、按最终用户、按地区 - 行业预测，2024-2031 年

2022年全球活细胞成像市场规模将为23亿美元，预测期内（2024-2031年）复合年增长率为8.2%，从2023年的24.9亿美元增加到2031年的46.7亿美元。上升。

由于成像技术投资的增加以及细胞研发需求的迅速增加，预计活细胞成像市场在未来几年将显着成长。特别是，活细胞成像在肿瘤学研究中的应用正在引起人们的关注，而针对干细胞研究的大量资金预计将进一步增加该领域的需求。随着全球药物发现和开发活动的扩大，以及政府资助和细胞治疗应用的增加，对活细胞成像的需求也预计会相应增加。此外，人工智慧和机器学习的整合已成为活细胞成像公司寻求在研究期间及之后获得市场占有率和创新的主要趋势。然而，该市场面临相当大的挑战，包括缺乏标准化、营运成本高、操作复杂性等，可能会阻碍其长期发展。总体而言，活细胞成像市场提供了由技术进步和对医疗保健中细胞应用的日益关注所驱动的机会，而持续的行业挑战使其无法充分发挥其潜力，这需要战略导航。

目录

介绍

• 研究目的
• 定义
• 市场范围

调查方法

• 资讯采购
• 二手资料来源和主要资料来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 市场概况展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 价值链分析
• 专利分析
• 技术分析
• 监管分析

活细胞影像市场：依产品/服务分类

• 市场概况
• 装置
  • 显微镜
  • 独立系统
  • 细胞分析仪
  • 配件
• 消耗品
  • 试剂
  • 检测试剂套件
  • 媒体
  • 其他消耗品
• 软体
• 服务

活细胞影像市场：依应用分类

• 市场概况
• 细胞生物学
• 发育生物学
• 干细胞和药物发现
• 其他的

活细胞影像市场：依技术分类

• 市场概况
• 延时显微镜
• 光漂白后的萤光恢復 (FRAP)
• 萤光共振能量转移 (FRET)
• 高内涵筛检（HCS）
• 其他的

活细胞成像市场：依最终用户分类

• 市场概况
• 製药和生物技术公司
• 学术研究所
• 合约调查机构

活细胞成像市场：按地区

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲地区

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市场占有率（2023年）

主要企业简介

• Thermo Fisher Scientific
• Danaher Corporation
• PerkinElmer, Inc.
• Carl Zeiss AG
• Nikon Corporation
• Olympus Corporation
• Bruker Corporation
• GE HealthCare
• Becton, Dickinson & Company
• Sartorius AG
• BioTek Instruments（Agilent）
• CytoSMART Technologies
• Oxford Instruments Andor Ltd
• Live Cell Imaging, Inc.
• Olympus Life Science
• Tecan Group
• Cytena GmbH（BICO）
• Merck KGaA

Global Live Cell Imaging Market was valued at USD 2.3 Billion in 2022 and is expected to rise from USD 2.49 Billion in 2023 to USD 4.67 Billion by 2031, at a CAGR of 8.2% during the forecast period (2024-2031).

The live cell imaging market is poised for significant growth in the coming years, driven by increasing investments in imaging technologies and a surging demand for cell research and development. A particular focus on utilizing live cell imaging in oncology research and substantial funding directed towards stem cell research are expected to further enhance demand in this sector. As global activities in drug discovery and development expand, alongside supportive government funding and an uptick in cell therapy applications, the demand for live cell imaging is anticipated to rise correspondingly. Additionally, the integration of artificial intelligence and machine learning is emerging as a crucial trend among live cell imaging companies aiming to innovate and capture market share throughout the study period and beyond. However, the market does face considerable challenges, including a lack of standardization, high operational costs, and complexities associated with operations, which may hinder its long-term development. Overall, while the live cell imaging market presents exciting opportunities fueled by technological advancements and increased focus on cellular applications in healthcare, ongoing industry challenges will require strategic navigation to fully realize its potential.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Live Cell Imaging market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Live Cell Imaging Market Segmental Analysis

Global Live Cell Imaging Market is segmented by Product & Service, Application, Technology, End User and Region. Based on Product & Service, the market is segmented into Instruments (Microscopes, Standalone Systems, Cell Analyzers, Accessories), Consumables (Reagents, Assay Kits, Media, Other Consumables), Software, Services. Based on Application, the market is segmented into Cell Biology, Developmental Biology, Stem Cell & Drug Discovery, and Others. Based on Technology, the market is segmented into Time lapse Microscopy, Fluorescence recovery after photobleaching (FRAP), Fluorescence resonance energy transfer (FRET), High content screening (HCS), and Others. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and Contract Research Organizations. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Live Cell Imaging Market

The surging focus of healthcare researchers on unlocking the intricate functionalities of cells is a significant market driver for the Global Live Cell Imaging market. As researchers aim to delve deeper into cellular behaviors, the demand for advanced cell-based technologies and products, particularly live cell imaging solutions, has escalated dramatically. This need is further amplified by the increasing recognition of the critical role that real-time observation of live cells plays in enhancing drug development, toxicology studies, and disease research. As innovation in imaging technologies progresses, the future landscape is set for robust growth, firmly establishing live cell imaging as an essential tool in cellular research.

Restraints in the Global Live Cell Imaging Market

One significant market restraint for the Global Live Cell Imaging market is the high cost associated with the development and procurement of advanced live cell imaging equipment and products. The intricate and sophisticated technologies involved in this field translate into substantial expenses for both the equipment and the consumables required for their operation. Consequently, research institutions operating under constrained budgets may find it challenging to invest in such high-end imaging solutions. This financial limitation can hinder the widespread adoption of live cell imaging techniques, ultimately restricting innovation and advancements within the research community and slowing overall market growth.

Market Trends of the Global Live Cell Imaging Market

The Global Live Cell Imaging market is witnessing a notable trend towards the adoption of advanced imaging technologies, particularly 3D and 4D imaging. As researchers seek deeper insights into cellular dynamics and interactions, the integration of these sophisticated imaging modalities is expected to significantly enhance the scope of live cell applications. This shift not only improves understanding of cellular structures but also facilitates real-time monitoring of biological processes. Consequently, companies in the live cell imaging sector are poised to leverage these advancements, driving innovation and expanding market potential as they cater to the evolving demands of the life sciences and biotechnology fields.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Value Chain Analysis
• Patent Analysis
• Technology Analysis
• Regulatory Analysis

Live Cell Imaging Market, By Product & Service

• Market Overview
• Instruments
  • Microscopes
  • Standalone Systems
  • Cell Analyzers
  • Accessories
• Consumables
  • Reagents
  • Assay Kits
  • Media
  • Other Consumables
• Software
• Services

Live Cell Imaging Market, By Application

• Market Overview
• Cell Biology
• Developmental Biology
• Stem Cell & Drug Discovery
• Others

Live Cell Imaging Market, By Technology

• Market Overview
• Time lapse Microscopy
• Fluorescence recovery after photobleaching (FRAP)
• Fluorescence resonance energy transfer (FRET)
• High content screening (HCS)
• Others

Live Cell Imaging Market, By End User

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Contract Research Organizations

Live Cell Imaging Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Carl Zeiss AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nikon Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE HealthCare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson & Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioTek Instruments (Agilent)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CytoSMART Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Instruments Andor Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Live Cell Imaging, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Life Science
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tecan Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cytena GmbH (BICO)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments